High infiltration of both cell types synergistically correlates with worse prognosis and unfavorable response to immunotherapy.<h4>Conclusions</h4>Our study delineates CAF heterogeneity in CRC and highlights the CTHRC1+ CAF subtype as a critical organizer of an immunosuppressive niche. The gene discussed is CTHRC1; the disease is colorectal carcinoma.